Primary central nervous system sarcoma with <i>DICER1</i> mutation—treatment results of a novel molecular entity in pediatric Peruvian patientsRosdali Díaz Coronado, Juan Luis García León, Luis Ojeda Medina et al.|Cancer|2021Cited by 41
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?Simon Bailey, Alan Davidson, Jeannette Parkes et al.|JCO Global Oncology|2022Cited by 31
Factors influencing outcomes of older children with medulloblastoma over 15 years in Peru, a resource‐limited settingRosdali Díaz Coronado, Diana S. Osorio, James B. Reinecke et al.|Pediatric Blood & Cancer|2022Cited by 11
HIGH-RISK HISTOPATHOLOGICAL FEATURES OF RETINOBLASTOMA FOLLOWING PRIMARY ENUCLEATIONSwathi Kaliki, Corrina P. Azarcon, Vijitha S. Vempuluru et al.|Retina|2024Cited by 6
Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral RetinoblastomaMattan Arazi, Alona Baum, Sandro Casavilca‐Zambrano et al.|American Journal of Ophthalmology|2024Cited by 2